Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications

Ternier G., Shahzad K., Edirisinghe O., Okoto P., Alraawi Z., Sonnaila S.

Narrative Review, published in Curr Drug Targets (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Curr Drug Targets (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40051360
PMCID
PMC13011824
DOI
10.2174/0113894501351461250301072444
Citations
7

Abstract (original English)

Several fibroblast growth factors are expressed in the developmental stage, while others are present in adults. They are vital in maintaining cellular homeostasis and signaling important cellular functions, such as regeneration and growth. Over the years, a spike of interest has been observed in clinical applications of the different members of this family, especially for their implications in glucose and lipid homeostasis, cancer, and regeneration. Yet, the extent of this vast family's roles in different cellular activities and their mechanism of action remain unclear. Furthermore, they are structurally unstable molecules, making clinical applications more difficult. This work reviews the mechanism of action of FGFs and offers valuable insights into their therapeutic potential.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansNeoplasmsGlucoseFibroblast Growth FactorsRegenerationSignal TransductionHomeostasis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.